RECEPTOR

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 4765
Amount: $45,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1986
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Oncogene Science Inc
222 Station Plaza North, Suite 330, Mineola, NY, 11501
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 JOHN R STEPHENSON
 PRINCIPAL INVESTIGATOR
 (516) 877-2882
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE EPIDERMAL GROWTH FACTOR RECEPTOR IS A 170,000 DALTON GLYCOPROTEIN COMPOSED OF THREE DOMAINS. THE CELL SURFACE DOMAIN BINDS EPIDERMAL GROWTH FACTOR (EGF) AND A LOW MOLECULAR WEIGHT, TUMOR-SPECIFIC GROWTH FACTOR (TGF ALPHA). AUTOCRINE STIMULATION OF THE EGF RECEPTOR OCCURS WHEN THE SAME TUMOR CELL POSSESSES EGF RECEPTORS AND PRODUCES TGF ALPHA. THE RECEPTOR HAS A HYDROPHOBIC MEMBRANE-SPANNING DOMAIN CONNECTING THE CELL SURFACE REGION WITH THE INTRA- CELLULAR TRYOSINE-SPECIFIC PROTEIN KINASE DOMAIN. THE EGF RECEPTOR SHARES REGIONS OF PRIMARY SEQUENCE HOMOLOGY WITH THE SRC FAMILY OF PROTEIN KINASES AND MOST CLOSELY RESEMBLESTHE V-ERB-B AND NEU GENES. EGF RECEPTOR AMPLIFICATION HAS BEEN DEMONSTRATED IN THE A431 CARCINOMA CELL LINE, RAISING THE POSSIBILITY THAT ELEVATED OR ABERRANT EGF RECEPTOR EXPRESSION MAY REPRESENT A DIAGNOSTICALLY USEFUL FEATURE OF CERTAIN CLASSES OF HUMAN CANCERS. IN THIS PHASE I PROJECT, METHODS WILL BE DEVELOPED FOR PREPARATIVE ISOLATION OF HUMANEGF RECEPTOR FROM A431 CELLS USING RICIN B CHAIN, ION EXCHANGE, AND EGF AFFINITY CHROMATOGRAPHY. THE PROTEIN KINASE C PHOSPHORYLATION SUBSTRATE SEQUENCE FLANKING THREONINE 654 WILL BE PRODUCED BY SOLID-PHASE PEPTIDE SYNTHESIS. MICE WILL BE IMMUNIZED, HYPERIMMUNE SERA PRODUCED, AND HYBRIDOMA FUSIONS INITIATED. FUTURE PHASE II EXPERIMENTS WILL BE DESIGNED TO DEVELOP PANELS OF MONOCLONALANTIBODIES TO BOTH NATIVE AND FORMALIN FIXED EGF RECEPTORS. THESE WILL BE ANALYZED FOR POTENTIAL USE IN HISTOPATHOLOGY, IN VIVO IMAGING, AND A SERUM-BASED ANTIGEN CAPTURE TEST FOR RECEPTOR PROTEIN.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government